Fred Burke - 11 Feb 2026 Form 4 Insider Report for Guardian Pharmacy Services, Inc. (GRDN)

Reporting relationship: President and Chief Executive Officer, Director
Issuer ticker: GRDN
Reported as of: 11 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Feb 2026, 16:05:05 UTC
Prior SEC filing: 08 Dec 2025
Next SEC filing: 24 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Douglas Towns, Attorney-in-Fact

Key filing fact

Fred Burke filed Form 4 for Guardian Pharmacy Services, Inc. (GRDN) on 13 Feb 2026.

Key facts

This page summarizes Fred Burke's Form 4 filing for Guardian Pharmacy Services, Inc. (GRDN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 Feb 2026, 16:05.

Change

Previous filing in this sequence was filed on 08 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002037972 Primary reporting owner

Burke Fred

Relationship: President and Chief Executive Officer, Director
Address: 300 GALLERIA PARKWAY SE, SUITE 800, ATLANTA
Signature: /s/ Douglas Towns, Attorney-in-Fact
Signature date: 13 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GRDN transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +75,000
Change %
Price: $0.000000
Shares after: 75,000
Date: 11 Feb 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 75,000
Exercise price: $34.59
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option shall vest and become exercisable in full on February 11, 2029.

SEC remarks

President and Chief Executive Officer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .